Value of diffusion-weighted and gadolinium-enhanced MRI for the diagnosis of pelvic recurrence from colorectal cancer

Journal of Magnetic Resonance Imaging

Volumn 40, Issue 2, 2014, Pages 306-313

  Colosio, Alban ^a   Soyer, Philippe ^b,c   Rousset, Pascal ^d   Barbe, Coralie ^e   Nguyen, Francis ^a   Bouché, Olivier ^e   Hoeffel, Christine ^a  

^a SERVICE DE DERMATOLOGIE   (France)

^b HÔPITAL LARIBOISIÈRE   (France)

^c UNIVERSITÉ PARIS DESCARTES   (France)

^d ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

^e HÔPITAL ROBERT DEBRÉ   (France)

Author keywords

diffusion weighted imaging; MR imaging; rectal cancer recurrence

Indexed keywords

GADOTERATE MEGLUMINE; CONTRAST MEDIUM; MEGLUMINE; ORGANOMETALLIC COMPOUND;

ADULT; AGED; ANASTOMOSIS LEAKAGE; ARTICLE; CANCER DIAGNOSIS; CANCER LOCALIZATION; CANCER RECURRENCE; COLORECTAL CANCER; CONTRAST ENHANCEMENT; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; DIFFUSION WEIGHTED IMAGING; FALSE NEGATIVE RESULT; FALSE POSITIVE RESULT; FEMALE; HUMAN; IMAGE ANALYSIS; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE SCANNER; PELVIC RECURRENCE; PELVIS CANCER; PRIORITY JOURNAL; PROSPECTIVE STUDY; RADIOLOGIST; RECTUM ABDOMINOPERINEAL RESECTION; TUMOR VOLUME; COLORECTAL NEOPLASMS; CONTROLLED STUDY; DIAGNOSTIC USE; IMAGE ENHANCEMENT; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PATHOLOGY; PELVIC NEOPLASMS; PROCEDURES; RANDOMIZED CONTROLLED TRIAL; REPRODUCIBILITY; SECONDARY; SENSITIVITY AND SPECIFICITY; TREATMENT OUTCOME; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; COLORECTAL NEOPLASMS; CONTRAST MEDIA; DIFFUSION MAGNETIC RESONANCE IMAGING; FEMALE; HUMANS; IMAGE ENHANCEMENT; MALE; MEGLUMINE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; ORGANOMETALLIC COMPOUNDS; PELVIC NEOPLASMS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; TREATMENT OUTCOME;

EID: 84904561957     PISSN: 10531807     EISSN: 15222586     Source Type: Journal    
DOI: 10.1002/jmri.24366     Document Type: Article

References (31)

1. Asgeirsson T, Zhang S, Senagore AJ,. Optimal follow-up to curative colon and rectal cancer surgery: how and for how long? Surg Oncol Clin N Am 2010; 19: 861-873.
2. Abir F, Alva S, Longo WE, Audiso R, Virgo KS, Johnson FE,. The postoperative surveillance of patients with colon cancer and rectal cancer. Am J Surg 2006; 192: 100-108. (Pubitemid 43849615)
3. Colosio A, Fornes P, Soyer P, Lewin M, Loock M, Hoeffel C,. Local colorectal cancer recurrence: pelvic MRI evaluation. Abdom Imaging 2013; 38: 72-81.
4. Arriola E, Navarro M, Pares D, et al. Imaging techniques contribute to increased surgical rescue of relapse in the follow-up of colorectal cancer. Dis Colon Rectum 2006; 49: 478-484.
5. Dresen RC, Kusters M, Daniels-Gooszen AW, et al. Absence of tumor invasion into pelvic structures in locally recurrent rectal cancer: prediction with preoperative MR imaging. Radiology 2010; 256: 143-150.
6. Flamen P, Stroobants S, Van Cutsem E, et al. Additional value of whole-body positron emission tomography with fluorine-18-2-deoxy-D-glucose in recurrent colorectal cancer. J Clin Oncol 1999; 17: 894-901. (Pubitemid 29109320)
7. Even-Sapir E, Parag Y, Lerman H, et al. Detection of recurrence in patients with rectal cancer: PET/CT after abdominoperineal or anterior resection. Radiology 2004; 232: 815-822. (Pubitemid 39100268)
8. Kau T, Reinprecht P, Eicher W, Lind P, Starlinger M, Hausseger KA,. FDG PET/CT in the detection of recurrent rectal cancer. Int Surg 2009; 94: 315-324.
9. Hoeffel C, Arrive L, Mourra N, Azizi L, Lewin M, Tubiana JM,. Anatomic and pathologic findings at external phased-array pelvic MR imaging after surgery for anorectal disease. Radiographics 2006; 26: 1391-1407. (Pubitemid 44518770)
10. Schaefer O, Langer M,. Detection of recurrent rectal cancer with CT, MRI and PET/CT. Eur Radiol 2007; 17: 2044-2054. (Pubitemid 47097462)
11. Blomqvist L, Fransson P, Hindmarsh T,. The pelvis after surgery and radio-chemotherapy for rectal cancer studied with Gd-DTPA-enhanced fast dynamic MR imaging. Eur Radiol 1998; 8: 781-787. (Pubitemid 128662636)
12. Torricelli P, Pecchi A, Luppi G, Romagnoli R,. Gadolinium-enhanced MRI with dynamic evaluation in diagnosing the local recurrence of rectal cancer. Abdom Imaging 2003; 28: 19-27. (Pubitemid 36460656)
13. Rao SX, Zeng MS, Chen CZ, et al. The value of diffusion-weighted imaging in combination with T2-weighted imaging for rectal cancer detection. Eur J Radiol 2008; 65: 299-303.
14. Sun YS, Zhang XP, Tang L, et al. Locally advanced rectal carcinoma treated with preoperative chemotherapy and radiation therapy: preliminary analysis of diffusionweighted MR imaging for early detection of tumor histopathologic downstaging. Radiology 2010; 254: 170-178.
15. Kim SH, Lee JM, Hong SH, et al. Locally advanced rectal cancer: added value of diffusion-weighted MR imaging in the evaluation of tumor response to neoadjuvant chemoand radiation therapy. Radiology 2009; 253: 116-125.
16. Curvo-Semedo L, Lambregts DM, Maas M, et al. Rectal cancer: assessment of complete response to preoperative combined radiation therapy with chemotherapy - conventional MR volumetry versus diffusion-weighted MR imaging. Radiology 2011; 260: 734-743.
17. DeLong ER, DeLong DM, Clarke-Pearson DL,. Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics 1988; 44: 837-845.
18. Fleiss JL,. Statistical methods for rates and proportions, 2nd edition. New York, NY: Wiley, 1981.
19. Markus J, Morrissey B, deGara C, Tarulli G,. MRI of recurrent rectosigmoid carcinoma. Abdom Imaging 1997; 22: 338-342.
20. Kinkel K, Tardivon AA, Soyer P, et al. Dynamic contrast-enhanced subtraction versus T2- weighted spin-echo MR imaging in the follow-up of colorectal neoplasm: a prospective study of 41 patients. Radiology 1996; 200: 453-458. (Pubitemid 26249899)
21. Gollub MJ, Gultekin DH, Akin O, et al. Dynamic contrast enhanced-MRI for the detection of pathological complete response to neoadjuvant chemotherapy for locally advanced rectal cancer. Eur Radiol 2012; 22: 821-831.
22. Vliegen RF, Beets GL, von Meyenfeldt MF, et al. Rectal cancer: MR imaging in local staging-is gadolinium-based contrast material helpful? Radiology 2005; 234: 179-188. (Pubitemid 39658384)
23. MERCURY Study Group. Diagnostic accuracy of preoperative magnetic resonance imaging in predicting curative resection of rectal cancer: prospectiveobservational study. BMJ 2006; 333: 779.
24. Lambregts DM, Cappendijk VC, Maas M, Beets GL, Beets-Tan RG,. Value of MRI and diffusion-weighted MRI for the diagnosis of locally recurrent rectal cancer. Eur Radiol 2011; 21: 1250-1258.
25. Nguyen TLF, Soyer P, Barbe C, et al. Diagnostic value of diffusion-weighted magnetic resonance imaging in pelvic abscesses. J Comput Assist Tomogr 2013. (in press).
26. Nishie A, Stolpen AH, Obuchi M, Kuehn DM, Dagit A, Andresen K,. Evaluation of locally recurrent pelvic malignancy: performance of T2- and diffusion-weighted MRI with image fusion. J Magn Reson Imaging 2008; 28: 705-713.
27. Morgan VA, Riches SF, Giles S, Dearnaley D, de Souza NM,. Diffusion-weighted MRI for locally recurrent prostate cancer after external beam radiotherapy. AJR Am J Roentgenol 2012; 198: 596-602.
28. Thoeny HC, Forstner R, De Keyzer F,. Genitourinary applications of diffusion-weighted MR imaging in the pelvis. Radiology 2012; 263: 326-342.
29. Lambregts DM, Vandecaveye V, Barbaro B, et al. Diffusion-weighted MRI for selection of complete responders after chemoradiation for locally advanced rectal cancer: a multicenter study. Ann Surg Oncol 2011; 18: 2224-2231.
30. Park MJ, Kim SH, Lee SJ, Jang KM, Rhim H,. Locally advanced rectal cancer: added value of diffusion-weighted MR imaging for predicting tumor clearance of the mesorectal fascia after neoadjuvant chemotherapy and radiation therapy. Radiology 2011; 260: 771-780.
31. Soyer P, Lagadec M, Sirol M, et al. Free-breathing diffusion-weighted single-shot echo-planar MR imaging using parallel imaging (GRAPPA 2) and high b value for the detection of primary rectal adenocarcinoma. Cancer Imaging 2010; 10: 32-39.